Cargando…
Thymosin β 10 is overexpressed and associated with unfavorable prognosis in hepatocellular carcinoma
Thymosin β 10 (TMSB10) has been demonstrated to be overexpressed and function as an oncogene in most types of human cancer including hepatocellular carcinoma (HCC). In our study, we present more evidence about the clinical significance and biological function of TMSB10 in HCC. First, we observed lev...
Autores principales: | Song, Chunrong, Su, Zhong, Guo, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418399/ https://www.ncbi.nlm.nih.gov/pubmed/30787051 http://dx.doi.org/10.1042/BSR20182355 |
Ejemplares similares
-
Thymosin Beta 4 and Thymosin Beta 10 Expression in Hepatocellular Carcinoma
por: Theunissen, W., et al.
Publicado: (2014) -
Overexpression of thymosin β10 correlates with disease progression and poor prognosis in bladder cancer
por: Wang, Bingwei, et al.
Publicado: (2019) -
Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2015) -
Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia
por: Guo, Chao, et al.
Publicado: (2020) -
High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy
por: Wang, Haoyuan, et al.
Publicado: (2014)